These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6547051

  • 1. Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Br J Cancer; 1984 May; 49(5):571-7. PubMed ID: 6547051
    [Abstract] [Full Text] [Related]

  • 2. RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
    Adams GE, Ahmed I, Sheldon PW, Stratford IJ.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1653-6. PubMed ID: 6548211
    [Abstract] [Full Text] [Related]

  • 3. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW, Maddison K, Wolf K.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM, Stratford IJ, Adams GE, Silver AR, Ahmed I, Jenkins TC, Fielden EM.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [Abstract] [Full Text] [Related]

  • 5. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR, Jenner TJ, O'Neill P, Fielden EM.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [Abstract] [Full Text] [Related]

  • 6. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP, Gulyas S, Whitmore GF.
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
    Stratford IJ, Adams GE, Godden J, Howells N.
    Int J Radiat Biol; 1989 Mar; 55(3):411-22. PubMed ID: 2564037
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
    Jenner TJ, O'Neill P, Crump PW, Fielden EM, Sapora O, Santodonato L.
    Biochem Pharmacol; 1991 Oct 09; 42(9):1705-10. PubMed ID: 1930296
    [Abstract] [Full Text] [Related]

  • 12. Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
    Walling J, Stratford IJ, Adams GE, Stephens MA.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1988 Apr 09; 53(4):641-9. PubMed ID: 3258298
    [Abstract] [Full Text] [Related]

  • 13. A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
    Suto MJ, Stier MA, Werbel LM, Arundel-Suto CM, Leopold WR, Elliott WE, Sebolt-Leopold JS.
    J Med Chem; 1991 Aug 09; 34(8):2484-8. PubMed ID: 1875345
    [Abstract] [Full Text] [Related]

  • 14. Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
    Dale LD, Widdick DA, Edwards DI, Biol GI.
    Int J Radiat Oncol Biol Phys; 1989 Apr 09; 16(4):995-9. PubMed ID: 2649469
    [Abstract] [Full Text] [Related]

  • 15. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B, Faddegon B, Skarsgard LD.
    Radiat Res; 1984 Nov 09; 100(2):340-7. PubMed ID: 6494445
    [Abstract] [Full Text] [Related]

  • 16. Chemosensitization in vitro: potentiation of melphalan toxicity by misonidazole, metronidazole and nitrofurazone.
    Smith E, Lumley CE, Stratford IJ, Adams GE.
    Int J Radiat Oncol Biol Phys; 1982 Nov 09; 8(3-4):615-7. PubMed ID: 7107383
    [Abstract] [Full Text] [Related]

  • 17. The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
    Stratford IJ, Walling JM, Silver AR.
    Br J Cancer; 1986 Mar 09; 53(3):339-44. PubMed ID: 3754453
    [Abstract] [Full Text] [Related]

  • 18. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S, Stratford IJ, Adams GE, Fielden EM, Jenkins TC.
    Radiat Res; 1990 Oct 09; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [Abstract] [Full Text] [Related]

  • 19. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
    Stratford IJ, Hickson ID, Robson CN, Stephens M.
    Int J Radiat Oncol Biol Phys; 1989 May 09; 16(5):1307-10. PubMed ID: 2523884
    [Abstract] [Full Text] [Related]

  • 20. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
    Teicher BA, Herman TS, Holden SA, Rudolph MB.
    Cancer Lett; 1991 Aug 09; 59(2):109-17. PubMed ID: 1884367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.